Professional Documents
Culture Documents
Lec 4 CNS
Lec 4 CNS
STATUS EPILEPTICUS
Pathophysiology
During status epilepticus there is increased cerebral metabolic rate and a compensatory
increase in cerebral blood flow that, after approximately 30 min, is not able to keep up with
the increases in cerebral metabolic rate. This leads to a transition from adequate to
inadequate cerebral oxygen tensions and, together with other factors, contributes to both
neuronal necrosis and apoptosis.
Etiology:
Investigation :
1) Laboratory studies: serum glucose, sodium, calcium , blood and spinal fluid cultures,
toxic screen and tests for inborn error of metabolism. Antiepileptic drug levels if patient is
already on an antiepileptic.
Management :
1) General steps
ABC :
The first priority of treatment is to ensure an adequate airway and to assess the
cardiovascular status
The child's oropharynx should be cleared and suctioned,
Oxygen is administered.
If there is any doubt concerning the adequacy of the airway, the child should be
intubated.
Proper positioning : put patient onside and gently hyperextend the neck and jaw to
enhance breathing
IV ACESS+ BL.SUGAR:
Diazepam:
- IV directly 0.1–0.3 mg/kg , may repeat in 5-10 min for a maximum of three doses.
- Rectally 0.3-0.5 mg/kg
- rectal gel 0.2–0.5 mg/kg.
- it carries a risk of apnea and hypotension,so it is given over 3-5 min when given iv
Midazolam:
Lorazepam :
ii. Phenytoin:
- loading dose 15- 20 mg/kg IV diluted with normal saline but not to glucose
solutions
- maintenance 5 mg/kg ÷ 2
- SE: the undiluted drug can cause pain, irritation, and phlebitis of the vein.
Arrhythmias and bradycardia rare, hypotension may also complicate IV
phenytoin .
Fosphenytoin
- water soluble
- less irritating after IV injection
- well absorbed after intramuscular injection
iii. Phenobarbital: In some centers, phenobarbital is initiated before phenytoin.
Loading in children 15-20 mg/kg and in neonates 20-30 mg/kg
Maintenance 3-5 mg/kg ÷ 2.
Refractory status epilepticus: is status epilepticus that has failed to respond to therapy, usually
with at least 2 medications (such as a benzodiazepine and another medication) .
iv. If the status convulsion is not controlled by the preceding strategy (no response in
10 minutes)
By this stage, the patient is usually sedated and may show signs of respiratory
depression, necessitating elective intubation and assisted ventilation.
The choices for further drug management include :
A diazepam infusion
Constant IV infusion of either midazolam (0.20 mg/kg bolus, 60–300 μg/kg/hr
infusion).or
Propofol (1–2 mg/kg bolus, 2–10 mg/kg/hr infusion).
Barbiturate coma, in an intensive care unit, the patient is placed on a ventilator
and a continuous EEG monitor. The initial IV loading dose of thiopental is 2–4
mg/kg
Paraldehyde, or is relatively safe for administration to children in a glass bottle ,
because the drug is incompatible with plastic ,diluted with D5W.
v. General anesthesia if conventional drug therapy is not effective or if barbiturate
coma is not an option. Several agents have been used successfully, including
halothane and isoflurane.
PROGNOSIS.
The mortality rate of status epilepticus is ≈5%. The greatest number of deaths
occur in the symptomatic group,
long-term sequelae such as hemiplegia, extrapyramidal syndromes, mental
retardation, and epilepsy are more common in children younger than 1 yr
The use of anticonvulsant therapy after status epilepticus is
controversialAnticonvulsant therapy is maintained arbitrarily for 3 mo in this
case and is discontinued if the child remains asymptomatic.
SEIZURES OF NEWBORN
Neonatal Seizures (NS) are the most important and common indicator of significant neurologic
dysfunction in the neonatal period. Its incidence is higher during this period than in any other period of
life.
1) The immature brain is more excitable and more likely to develop seizures, but it appears to be
more resistant to the harmful effects of seizures than the mature brain
2) Neonatal seizures are dissimilar from those in a child or adult because generalized tonic-
clonic convulsions tend not to occur in the 1st mo of life. The branching of axons and
dendritic processes as well as myelination is incomplete in the neonatal brain. A seizure
discharge, therefore, cannot readily be propagated throughout the neonatal brain to produce a
generalized seizure.
Differential diagnosis
Jitteriness & tremor:
jitteriness is characterized by fine, rapid movement which can be elicited by stimuli,and
interrupted by holding the extremity ,not associated with abnormal eye movements and
absence of autonomic changes (tachycardia, salivation)
Investigations
1- Immediate determination of capillary blood glucose with strip.
2- blood glucose,calcium,sodium,&bilirubin determination.
3- when infection suspected cerebrospinal fluid and blood culture.
Treatment
1- Specific: such as treatment of meningitis, hypoglycemia, hypocalcemia, hypomagnesemia,
hyponatremia, or vit b6 deficency or dependency.
2- Treatment of seizure:
Phenobarbital is considered the first drug of choice The usual loading dose is 20 mg/kg. If this
dosage is not effective, the dose can be increased until amaximum dose of 40 mg/kg is reached.
Maintenance dose usually started 24 hr after the loading dose as 3-6 mg/kg/day ÷ 2
Phenytoin can only be started when the total loading dose of phenobarbital that reached 40 mg/kg
was not effective. The loading dose is 15-20 mg/kg, usually given by infusion (not in dextrose
solutions) with monitoring of HR to prevent cardiac dysrhythmia. Maintenance dose 4-8 mg/kg/day.
Diazepam is highly lipophilic, it distributes very rapidly into the brain and then is cleared very quickly
out (which carry a risk of recurrence of seizures). The usual dose is 0.1-0.3 mg/kg IV over 3-5 min,
given every 15-30 min to a maximum total dose of 2 mg. Diazepam is currently not recommended as
a first-line agent for neonatal seizures because it carries a higher risk of apnea and hypotension,
especially if the pt is also on phenobarbital, thus patients should be observed for 3-8 hr after
administration.
Second and third choice for neonatal Seizures :Levetiracetam (Keppra) and Topiramate(Topamax)
NEUROCUTANEOUS DISORDERS
The skin , teeth , hair , nail and the brain are derived embryologically from ectoderm , so abnormalities
in these structure may be associated with abnormal brain development. these include:
Neurofibromatosis
Tuberous sclerosis
Sturge-weber disease
Ataxia telangiectasia
Neurofibromatosis (NF)
A.D disorder.
Cardinal feature of disorder are café-au-lait spots , axiliary freckling , cutaneous
neurofibromas , iris hamartomas
There are two types of NF, NF-1 and NF-2
1. Six or more café-au-lait spots (size should be: in pretpubertal individuals >0.5cm , in
postpubertal individuals >1.5cm)it is the hallmark of neurofibromatosis and are present in
almost 100% of patients.
2. Two or more neurofibromas or one plexiform neurofibroma
4. Optic glioma.
6. Distinctive bone lesion such as sphenoid dysplasia which may cause pulsating
exophthalmos.
Complication:
Retinal hamartoma
Renal hamartoma
Cardiac rhabdomyoma
Mental retardation
Myoclonic atonic, partial , grand mal seizures
Diagnosis :
Clinical suspicion
Typical skin lesions
CT / MRI
Treatment:
Control of seizure
Educational services for MR
Cosmetic
Monitoring & follow up of systemic involvement
Sturge-Weber Syndrome
Angioma of the leptomeninges(arachnoid and pia mater) overlying the cerebral cortex in association
with ipsilateral facial port-wine nevus (in the 5th cranial N. distribution ).
Diagnosis